Defective membrane remodeling in neuromuscular diseases: Insights from animal models

PLoS Genetics

Volumn 8, Issue 4, 2012, Pages

  Cowling, Belinda S ^a,b,c,d,e   Toussaint, Anne ^a,b,c,d,e   Muller, Jean ^a,b,c,d,e,f   Laporte, Jocelyn ^a,b,c,d,e  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e l'alimentation et l'Environnement   (France)

^f HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHYSIN; AMPHIPHYSIN 2; DYNAMIN; DYNAMIN I; DYNAMIN II; MYOTUBULARIN 6 PROTEIN; MYOTUBULARIN PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; UNCLASSIFIED DRUG; MYOTUBULARIN; NERVE PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE;

AMPH1 GENE; AMPHIPHYSIN 2 GENE; CAENORHABDITIS ELEGANS; CENTRONUCLEAR MYOPATHY; DISEASE MODEL; DNM1 GENE; DNM2 GENE; DROSOPHILA; ENDOCYTOSIS; GENE; GENE EXPRESSION PROFILING; GENETIC CODE; HUMAN; MEMBRANE BIOLOGY; MEMBRANE REMODELING; MOLECULAR MECHANICS; MTMR13 GENE; MTMR2 GENE; MUSCLE FUNCTION; MYOTUBULARIN GENE; NERVE FUNCTION; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; SKELETAL MUSCLE; ZEBRA FISH; ANIMAL; CELL MEMBRANE; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYLOGENY;

ANIMALIA;

ANIMALS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; DYNAMINS; HUMANS; MUTATION; NERVE TISSUE PROTEINS; NEUROMUSCULAR DISEASES; PHYLOGENY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR;

EID: 84860562008     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002595     Document Type: Review

References (89)

1. De Matteis MA, Luini A, (2011) Mendelian disorders of membrane trafficking. N Engl J Med 365: 927-938.
2. van Wijngaarden GK, Fleury P, Bethlem J, Meijer AE, (1969) Familial "myotubular" myopathy. Neurology 19: 901-908.
3. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: 175-182.
4. Senderek J, Bergmann C, Weber S, Ketelsen UP, Schorle H, et al. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 12: 349-356.
5. Azzedine H, Bolino A, Taieb T, Birouk N, Di Duca M, et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-ooth disease associated with early-onset glaucoma. Am J Hum Genet 72: 1141-1153.
6. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25: 17-19.
7. Suter U, Scherer S, (2003) Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 4: 714-726.
8. Nicot AS, Laporte J, (2008) Endosomal phosphoinositides and human diseases. Traffic 9: 1240-1249.
9. Di Paolo G, De Camilli P, (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443: 651-657.
10. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA, (2008) Phosphoinositides as regulators of membrane trafficking in health and disease. Cell Mol Life Sci 65: 2833-2841.
11. Laporte J, Bedez F, Bolino A, Mandel J-L, (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet 12: 285-292.
12. Begley MJ, Dixon JE, (2005) The structure and regulation of myotubularin phosphatases. Curr Opin Struct Biol 15: 614-620.
13. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, et al. (1998) Association of SET domain and myotubularin-related proteins modulates growth control. Nat Genet 18: 331-337.
14. Laporte J, Blondeau F, Buj-Bello A, Tentler D, Kretz C, et al. (1998) Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. Hum Mol Genet 7: 1703-1712.
15. Zou J, Chang S, Marjanovic J, Majerus P, (2009) MTMR9 increases MTMR6 enzyme activity, stability, and role in apoptosis. J Biol Chem 2009 284: 2064-2071.
16. Nandurkar HH, Layton M, Laporte J, Selan C, Corcoran L, et al. (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc Natl Acad Sci U S A 100: 8660-8665.
17. Mochizuki Y, Majerus PW, (2003) Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc Natl Acad Sci U S A 100: 9768-9773.
18. Kim SA, Vacratsis PO, Firestein R, Cleary ML, Dixon JE, (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc Natl Acad Sci U S A 100: 4492-4497.
19. Robinson FL, Dixon JE, (2005) The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease. J Biol Chem 280: 31699-31707.
20. Velichkova M, Juan J, Kadandale P, Jean S, Ribeiro I, et al. (2010) Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J Cell Biol 190: 407-425.
21. Ribeiro I, Yuan L, Tanentzapf G, Dowling JJ, Kiger A, (2011) Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance. PLoS Genet 7: e1001295 doi:10.1371/journal.pgen.1001295.
22. Laporte J, Blondeau F, Buj-Bello A, Mandel JL, (2001) The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet 17: 221-228.
23. Wishart MJ, Taylor GS, Slama JT, Dixon JE, (2001) PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr Opin Cell Biol 13: 172-181.
24. Xue Y, Fares H, Grant B, Li Z, Rose AM, et al. (2003) Genetic analysis of the myotubularin family of phosphatases in caenorhabditis elegans. J Biol Chem 278: 34380-34386.
25. Fares H, Greenwald I, (2001) Genetic analysis of endocytosis in Caenorhabditis elegans: coelomocyte uptake defective mutants. Genetics 159: 133-145.
26. Dang H, Li Z, Skolnik EY, Fares H, (2004) Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol Biol Cell 15: 189-196.
27. Silhankova M, Port F, Harterink M, Basler K, Korswagen HC, (2010) Wnt signalling requires MTM-6 and MTM-9 myotubularin lipid-phosphatase function in Wnt-producing cells. EMBO J 29: 4094-4105.
28. Zou W, Lu Q, Zhao D, Li W, Mapes J, et al. (2009) Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells. PLoS Genet 5: e1000679 doi:10.1371/journal.pgen.1000679.
29. Neukomm LJ, Nicot AS, Kinchen JM, Almendinger J, Pinto SM, et al. (2011) The phosphoinositide phosphatase MTM-1 regulates apoptotic cell corpse clearance through CED-5-CED-12 in C. elegans. Development 138: 2003-2014.
30. Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, et al. (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 5: e1000372 doi:10.1371/journal.pgen.1000372.
31. Robb SA, Sewry CA, Dowling JJ, Feng L, Cullup T, et al. (2011) Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. Neuromuscul Disord 21: 379-386.
32. Shen J, Yu WM, Brotto M, Scherman JA, Guo C, et al. (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol 11: 769-776.
33. Hnia K, Kretz C, Amoasii L, Bohm J, Liu X, et al. (2011) Primary T-tubule and autophagy defects in the phosphoinositide phosphatase Jumpy/MTMR14 knockout mice muscle. Adv Enzyme Regul In press.
34. Buj-Bello A, Laugel V, Messaddeq N, Zahreddine H, Laporte J, et al. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A 99: 15060-15065.
35. Al-Qusairi L, Weiss N, Toussaint A, Berbey C, Messaddeq N, et al. (2009) T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A 106: 18763-18768.
36. Toussaint A, Cowling BS, Hnia K, Mohr M, Oldfors A, et al. (2011) Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol 121: 253-266.
37. Beggs AH, Bohm J, Snead E, Kozlowski M, Maurer M, et al. (2010) MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci U S A 107: 14697-14702.
38. Hnia K, Tronchere H, Tomczak KK, Amoasii L, Schultz P, et al. (2011) Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest 121: 70-85.
39. Buj-Bello A, Fougerousse F, Schwab Y, Messaddeq N, Spehner D, et al. (2008) AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet 17: 2132-2143.
40. Bolino A, Bolis A, Previtali SC, Dina G, Bussini S, et al. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol 167: 711-721.
41. Bolis A, Coviello S, Bussini S, Dina G, Pardini C, et al. (2005) Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J Neurosci 25: 8567-8577.
42. Bonneick S, Boentert M, Berger P, Atanasoski S, Mantei N, et al. (2005) An animal model for Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 14: 3685-3695.
43. Tersar K, Boentert M, Berger P, Bonneick S, Wessig C, et al. (2007) Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. Hum Mol Genet 16: 2991-3001.
44. Robinson FL, Niesman IR, Beiswenger KK, Dixon JE, (2008) Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. Proc Natl Acad Sci U S A 105: 4916-4921.
45. Berger P, Berger I, Schaffitzel C, Tersar K, Volkmer B, et al. (2006) Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum Mol Genet 15: 569-579.
46. Nicot AS, Toussaint A, Tosch V, Kretz C, Wallgren-Pettersson C, et al. (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39: 1134-1139.
47. Bohm J, Yis U, Ortac R, Cakmakci H, Kurul SH, et al. (2010) Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation. Orphanet J Rare Dis 5: 35.
48. Peter BJ, Kent HM, Mills IG, Vallis Y, Butler PJ, et al. (2004) BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science 303: 495-499.
49. Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J, Prendergast GC, (1997) Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing. J Biol Chem 272: 31453-31458.
50. Wechsler-Reya RJ, Elliott KJ, Prendergast GC, (1998) A role for the putative tumor suppressor Bin1 in muscle cell differentiation. Mol Cell Biol 18: 566-575.
51. Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, et al. (2002) Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 297: 1193-1196.
52. De Camilli P, Thomas A, Cofiell R, Folli F, Lichte B, et al. (1993) The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J Exp Med 178: 2219-2223.
53. Razzaq A, Robinson IM, McMahon HT, Skepper JN, Su Y, et al. (2001) Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev 15: 2967-2979.
54. Pant S, Sharma M, Patel K, Caplan S, Carr C, et al. (2009) AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling. Nat Cell Biol 11: 1399-1410.
55. Muller AJ, Baker JF, DuHadaway JB, Ge K, Farmer G, et al. (2003) Targeted disruption of the murine Bin1/Amphiphysin II gene does not disable endocytosis but results in embryonic cardiomyopathy with aberrant myofibril formation. Mol Cell Biol 23: 4295-4306.
56. Di Paolo G, Sankaranarayanan S, Wenk MR, Daniell L, Perucco E, et al. (2002) Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice. Neuron 33: 789-804.
57. Kusumi N, Watanabe M, Yamada H, Li SA, Kashiwakura Y, et al. (2007) Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release. Cell Struct Funct 32: 101-113.
58. Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, et al. (2005) Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37: 1207-1209.
59. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37: 289-294.
60. Bitoun M, Bevilacqua JA, Eymard B, Prudhon B, Fardeau M, et al. (2009) A new centronuclear myopathy phenotype due to a novel dynamin 2 mutation. Neurology 72: 93-95.
61. Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, et al. (2007) Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol 62: 666-670.
62. Echaniz-Laguna A, Nicot AS, Carre S, Franques J, Tranchant C, et al. (2007) Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Neuromuscul Disord 17: 955-959.
63. Schessl J, Medne L, Hu Y, Zou Y, Brown MJ, et al. (2007) MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord 17: 28-32.
64. Praefcke GJ, McMahon HT, (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5: 133-147.
65. Jones SM, Howell KE, Henley JR, Cao H, McNiven MA, (1998) Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 279: 573-577.
66. McNiven MA, Cao H, Pitts KR, Yoon Y, (2000) The dynamin family of mechanoenzymes: pinching in new places. Trends Biochem Sci 25: 115-120.
67. Durieux AC, Prudhon B, Guicheney P, Bitoun M, (2010) Dynamin 2 and human diseases. J Mol Med 88: 339-350.
68. Ramaswami M, Krishnan K, Rb K, (1994) Intermediates in synaptic vesicle recycling revealed by optical imaging of Drosophila neuromuscular junctions. Neuron 13: 363-375.
69. Kosaka T, Ikeda K, (1983) Reversible blockage of membrane retrieval and endocytosis in the garland cell of the temperature-sensitive mutant of Drosophila melanogaster, shibirets1. J Cell Biol 97: 499-507.
70. Estes PS, Roos J, van der Bliek A, Kelly RB, Krishnan KS, et al. (1996) Traffic of dynamin within individual Drosophila synaptic boutons relative to compartment-specific markers. J Neurosci 16: 5443-5456.
71. Tsuruhara T, Koenig J, Ikeda K, (1990) Synchronized endocytosis studied in the oocyte of a temperature-sensitive mutant of Drosophila melanogaster. Cell Tissue Res 259: 199-207.
72. Johnson E, Ringo J, Dowse H, (2001) Dynamin, encoded by shibire, is central to cardiac function. J Exp Zool 289: 81-89.
73. Clark SG, Shurland DL, Meyerowitz EM, Bargmann CI, van der Bliek AM, (1997) A dynamin GTPase mutation causes a rapid and reversible temperature-inducible locomotion defect in C. elegans. Proc Natl Acad Sci U S A 94: 10438-10443.
74. Labrousse A, Shurland D, van der Bliek A, (1998) Contribution of the GTPase domain to the subcellular localization of dynamin in the nematode Caenorhabditis elegans. Mol Biol Cell 9: 3227-3239.
75. Yu X, Odera S, Chuang CH, Lu N, Zhou Z, (2006) C. elegans Dynamin mediates the signaling of phagocytic receptor CED-1 for the engulfment and degradation of apoptotic cells. Dev Cell 10: 743-757.
76. Nakayama Y, Shivas J, Poole D, Squirrell J, Kulkoski J, et al. (2009) Dynamin participates in the maintenance of anterior polarity in the Caenorhabditis elegans embryo. Dev Cell 16: 889-900.
77. Ferguson SM, Brasnjo G, Hayashi M, Wolfel M, Collesi C, et al. (2007) A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 316: 570-574.
78. Raimondi A, Ferguson SM, Lou X, Armbruster M, Paradise S, et al. (2011) Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron 70: 1100-1114.
79. Patterson EE, Minor KM, Tchernatynskaia AV, Taylor SM, Shelton GD, et al. (2008) A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse. Nat Genet 40: 1235-1239.
80. Ferguson SM, Raimondi A, Paradise S, Shen H, Mesaki K, et al. (2009) Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Dev Cell 17: 811-822.
81. Durieux AC, Vignaud A, Prudhon B, Viou MT, Beuvin M, et al. (2010) A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice. Hum Mol Genet 19: 4820-4836.
82. Cowling BS, Toussaint A, Amoasii L, Koebel P, Ferry A, et al. (2011) Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Am J Pathol 178: 2224-2235.
83. Reilly MM, Murphy SM, Laura M, (2011) Charcot-Marie-Tooth disease. J Peripher Nerv Syst 16: 1-14.
84. Hernandez-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, et al. (2006) Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum Mol Genet 15: 129-142.
85. Klinge L, Harris J, Sewry C, Charlton R, Anderson L, et al. (2010) Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle. Muscle Nerve 41: 166-173.
86. Wang L, Barylko B, Byers C, Ross JA, Jameson DM, et al. (2010) Dynamin 2 mutants linked to centronuclear myopathies form abnormally sTable polymers. J Biol Chem 285: 22753-22757.
87. Kenniston JA, Lemmon MA, (2010) Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients. Embo J 29: 3054-3067.
88. Owen DJ, Wigge P, Vallis Y, Moore JD, Evans PR, et al. (1998) Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation. Embo J 17: 5273-5285.
89. Bolino A, Marigo V, Ferrera F, Loader J, Romio L, et al. (2002) Molecular characterization and expression analysis of Mtmr2, mouse homologue of MTMR2, the Myotubularin-related 2 gene, mutated in CMT4B. Gene 283: 17-26.